{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:49:21Z","timestamp":1785883761033,"version":"3.56.0"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":295,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Ophthalmology"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:p><jats:italic>Objective<\/jats:italic>To compare the reduction in intraocular pressure (IOP) by topical 2% dorzolamide to oral methazolamide (5 mg\/kg) in dogs, and determine if the combination of both drugs would reduce IOP more than either drug administered alone.<\/jats:p><jats:p><jats:italic>Animals studied<\/jats:italic>Thirteen glaucomatous beagles.<\/jats:p><jats:p><jats:italic>Procedures<\/jats:italic>Measurements, including applanation tonometry, pupil size and heart rate, were obtained at 8 am, 12 noon, and 5 pm on days 1, 3 and 5. The 5\u2010day drug studies included placebo (0.5% methylcellulose); 2% dorzolamide administered in one eye twice daily (8 am and 5 pm), and repeated again in one eye three times (8 am, 12 noon and 5 pm) daily; methazolamide (5 mg\/kg per os administered at 8 am and 5 pm); 2% dorzolamide instilled twice daily (5 days) combined with oral methazolamide on the last 3 days, and methazolamide (5 days) combined with 2% dorzolamide on the last 3 days and instilled twice daily. Statistical comparisons between drug groups included control (nondrug) eye and treated (placebo\/drug) eyes for days 1, day 3 and 5.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>Topical 2% dorzolamide, administered twice and three times daily, significantly decreased IOP (mean\u2003\u00b1\u2003SEM) in glaucomatous dogs on the first day (twice daily 7.6\u2003\u00b1\u20032.4 mmHg, and three times daily 16.4\u2003\u00b1\u20033.6 mmHg) that was even greater by day 5 (twice daily 10.4\u2003\u00b1\u20032.0 mmHg, and three times daily 13.9\u2003\u00b1\u20032.7). Oral methazolamide also significantly lowered IOP in both eyes. Oral methazolamide (administered from day 1 through to day 5) combined with 2% topical dorzolamide (instilled in the drug eye for day 3 through to day 5) also significantly lowered IOP of both eyes for all days, and for day 5 the mean\u2003\u00b1\u2003SEM IOP was decreased by 7.9\u2003\u00b1\u20031.7 mmHg (methazolamide plus dorzolamide) and 7.5\u2003\u00b1\u20032.6 mmHg (methazolamide only). Topical dorzolamide (instilled in the drug eye for day 1 through to day 5) combined with oral methazolamide (administered from day 3 through to day 5) significantly lowered IOP in the drug eye on day 1 (5 pm: 9.6\u2003\u00b1\u20031.9 mmHg), for day 3 (11 am and 5 pm) and for all of day 5 for both eyes (5 pm: control eye 9.5\u2003\u00b1\u20031.8 mmHg; drug eye 9.2\u2003\u00b1\u20031.9 mmHg). Topical dorzolamide (2%) instilled three times daily produces similar IOP declines compared to the combination of oral methazolamide and 2% dorzolamide administered twice daily.<\/jats:p><jats:p><jats:italic>Conclusions<\/jats:italic>Dorzolamide (2%) instilled twice or three times daily causes significant decreases in IOP in glaucomatous dogs. Twice daily instillations caused progressive declines in IOP from day 1 to day 5. Dorzolamide (2%) combined with oral methazolamide (5 mg\/kg per os twice daily) produces similar but not additional declines in IOP.<\/jats:p>","DOI":"10.1046\/j.1463-5224.2001.00141.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T23:36:05Z","timestamp":1047512165000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs"],"prefix":"10.1111","volume":"4","author":[{"given":"Kirk N.","family":"Gelatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward O.","family":"MacKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(60)91346-5"},{"key":"e_1_2_6_3_2","first-page":"730","article-title":"The pharmacology of methazolamide in relation to the treatment of glaucoma","volume":"16","author":"Maren TH","year":"1977","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"e_1_2_6_4_2","unstructured":"GelattKN&BrooksDE.The canine glaucomas. In:Veterinary Ophthalmology 3rd edn. (ed. Gelatt KN) Lippincott\/Williams & Wilkins Baltimore 1999;701\u2013754."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1997.13.23"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(97)00053-2"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1992.01080160073033"},{"key":"e_1_2_6_8_2","first-page":"334","article-title":"Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles","volume":"40","author":"Gelatt KN","year":"1979","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_9_2","first-page":"125126.","article-title":"Effects of chronic administration of an oral carbonic anhydrase inhibitor (dichlorphenamide) on intraocular pressure and serum potassium levels in the normal canine","volume":"24","author":"Pickett JP","year":"1993","journal-title":"Proceedings of the American College of Veterinary Ophthalmologists"},{"key":"e_1_2_6_10_2","first-page":"792","article-title":"Effect of acetazolamide on blood acid\u2010base and electrolyte values in dogs","volume":"179","author":"Haskins SC","year":"1981","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_11_2","first-page":"1417","article-title":"Efficacy of various diuretics in normal dogs","volume":"146","author":"Hamlin RL","year":"1965","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_12_2","unstructured":"StaritaRJ Piltz\u2010SeymourJR FellmanRL.Ocular and systemic side effects of carbonic anhydrase inhibitors. In:Complications of Glaucoma Therapy.(eds Sherwood MB Spaeth GL) Slack Incorporated Thorofare New Jersey 1990;57\u201376."},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1996.12.363"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1991.01080090123036"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1993.1100"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1999.15.51"},{"key":"e_1_2_6_17_2","first-page":"175","article-title":"Evaluation of a topical carbonic anhydrase inhibitor (MK\u2010927) in normotensive and glaucomatous dogs","volume":"21","author":"King TC","year":"1990","journal-title":"Proceedings of the American College of Veterinary Ophthalmologists"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2460\/ajvr.1991.52.12.2067","article-title":"Evaluation of a topically administered carbonic anhydrase inhibitor (MK\u2010927) in normotensive and glaucomatous Beagles","volume":"52","author":"King TC","year":"1991","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_19_2","unstructured":"SAS\/STATGuide for Personal Computers Version 6ed. SAS Institute Inc. Cary NC 1991."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1997.0167"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1997.01100150047008"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)91421-X"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.1.19"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.1998.760618.x"}],"container-title":["Veterinary Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1463-5224.2001.00141.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1463-5224.2001.00141.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1463-5224.2001.00141.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:16:52Z","timestamp":1733959012000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1463-5224.2001.00141.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1046\/j.1463-5224.2001.00141.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1463-5224.2001.00141.x","archive":["Portico"],"relation":{},"ISSN":["1463-5216","1463-5224"],"issn-type":[{"value":"1463-5216","type":"print"},{"value":"1463-5224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"2001-12-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}